BOARD OF DIRECTORS
Klas Arildsson
Chairman of the Board since 2020

Klas Arildsson has extensive experience in global operations, medical device and life science. Most recently he served as VP Operations Getinge Infection Control AB and previously led business areas for two other medical device companies as Senior VP of Global Supply Chain at Gambro Renal Products and VP Supply Chain Manufacturing at Baxter Inc. Additional past roles include VP of Operations at Cardo Door and Quality Manager and Plant Manager at Ericsson Telecom. Previous Board assignments include Gambro Lundia AB, Lund Nyföretagarcentrum and Life Assays AB.

  • Other appointments: Chairman of the Board Kristianstad Österlen Airport, Board member of Redsense Medical AB, Board member of Gambro Lundia AB, and  member of Lund University’s Business Council.
  • Education: Mr. Arildsson completed the KTH Royal Institute of Technology Executive Management Program.
  • Born: 1960
  • Holdings: 50 000 shares, 300 000 options issued by Dignitana and 300 000 options issued by Adma Förvaltnings AB
  • Independence: Independent in relation to the company, the company’s senior executives and major shareholders of the company.
William Cronin
Chief Executive Officer
Board Member since 2015
William Cronin began his career in finance, starting with Shearson Lehman Brothers in New York in 1987 and then moving to Dallas in 1992 to work with Capital Institutional Services as their Head of International Sales and Trading. After leaving CIS in 1999, Mr. Cronin became President of Direct Trading Institutional, an early pioneer in high speed electronic trading, which was ultimately sold to Knight Capital Group (KCG: NYSE).

Mr. Cronin became involved with scalp cooling after his wife’s diagnosis with breast cancer in 2011. After her success with scalp cooling, together they founded Chemo Cold Caps, LLC, one of the largest US-based providers of manual scalp cooling solutions to patients. Mr. Cronin began working with Dignitana in 2014 as the company’s clinical trial was being completed, becoming COO of the US subsidiary after FDA clearance in 2015.  He was appointed CEO of Dignitana Inc. in 2016 and of AB in November 2017.

  • Other appointments: Chairman of the Board of C3 Device Partners
  • Education: Mr. Cronin holds BA from Muhlenberg College in Pennsylvania and has a Master’s in Business Administration in Finance from the University of Texas, Dallas.
  • Born: 1965
  • Holdings: 4 189 739 through shareholding in C3 Device Partners
  • Independence: Dependent in relation to the company, the company’s senior executives and major shareholders of the company.
richard DiIorio
Board Member since 2020

Richard DiIorio

 

Richard DiIorio is President & CEO of InfuSystem Holdings (INFU), a leading U.S. healthcare company providing medical devices and services to hospitals, home infusion providers, oncology practices and patients. He has a strong track record of accomplishment with more than 20 years of medical sales experience, expertise in product launch, and industry knowledge focused on driving growth in the oncology market. Previously he held various sales and sales leadership roles at Stryker Medical, Novartis Pharmaceuticals, and Thermo Scientific.

  • Other appointments:  Director, InfuSystem Holdings
  • Education: Mr. DiIorio earned a Bachelor of Science degree in Biology from Boston College.
  • Born: 1974
  • Holdings: none
  • Independence: Independent in relation to the company, the company’s senior executives and major shareholders of the company.

Lina Karlsson

Board Member since 2021
LIna Karlsson

Lina Karlsson has demonstrated significant success with product development and organizational development in the medical industry. Experienced in several areas such as R&D, strategy, and operations, she has a proven track record in operational excellence work with a focus on cost reductions and quality improvements and a strong interest in organizational optimization, business development, and general management.

She holds the position as Director R&D, Surgical Solutions for Mölnlycke Healthcare but is currently moving into a new role as Executive VP for Business area Antiseptics in the same company. After completing post-doctorate work at Astra Zeneca she joined Gambro AB where she held several leadership roles in Global R&D and Operations. After integration to Baxter, she joined the global R&D team where held the position of Director Renal R&D, HD Therapy, and site manager for the Baxter Lund R&D site.

  • Other appointments: none
  • Education: Ms. Karlsson attended Lund University where she received a Master’s degree in Chemical Engineering and a PhD in Polymer Science and Engineering. She received an Executive MBA from the Executive Foundation Lund and is currently enrolled there as well in the Board of Directors training program
  • Born: 1973
  • Holdings: none
  • Independence: Independent in relation to the company, the company’s senior executives and major shareholders of the company.

Christian Lindgren

Board Member since 2020

Christian Lindgren has extensive experience in the investment sector and serves as CEO of Adma Förvaltnings AB. He previously served as CFO and administrative head of companies such as HSB Malmö, Sparbanken Syd, Meaning Green and CFO and later CEO of Active Capital AB.

  • Other appointments: CEO at Adma Förvaltnings AB and member of board in Doxa AB, Kollektiva Innovations Studio AB, Safeture AB and Grosshold AB.
  • Education: Mr. Lindgren attended School of Business, Economics and Law at University of Gothenburg.
  • Born: 1974
  • Holdings: none
  • Independence: Independent of executive management but not independent of major shareholder.

Ljubo Mrnjavac

Board Member since 2020

Ljubo Mrnjavac has demonstrated success in the investment management industry and is Head of Investment at Adma Förvaltnings AB. He has broad entrepreneurial experience and is founder of Pölsemannen and co-founder and CEO of venture capital company Rosengård Invest. Previous roles include CEO of Tulip Food Concepts and founder and CEO of Scandinavian Cap.

  • Other appointments: Board member of Lund University Food Science, operates the football club FC Rosengård
  • Education: Mr. Mrnjavac attended IHM Business School and received an MBA from Lund University.
  • Born: 1963
  • Holdings: 90 000
  • Independence: Independent of executive management but not independent of major shareholder.
SENIOR EXECUTIVES

WILLIAM CRONIN

Chief Executive Office of Dignitana AB since 2017 (at Dignitana since 2014)
Born 1965

William Cronin began his career in finance, starting with Shearson Lehman Brothers in New York in 1987 and then moving to Dallas in 1992 to work with Capital Institutional Services as their Head of International Sales and Trading. After leaving CIS in 1999, Mr. Cronin became President of Direct Trading Institutional, an early pioneer in high speed electronic trading, which was ultimately sold to Knight Capital Group (KCG: NYSE).

Mr. Cronin became involved with scalp cooling after his wife’s diagnosis with breast cancer in 2011. After her success with scalp cooling, together they founded Chemo Cold Caps, LLC, one of the largest US-based providers of manual scalp cooling solutions to patients. Mr. Cronin began working with Dignitana in 2014 as the company’s clinical trial was being completed, becoming COO of the US subsidiary after FDA clearance in 2015.  He was appointed CEO of Dignitana Inc. in 2016 and of AB in November 2017.

  • Other appointments: Chairman of the Board of C3 Device Partners
  • Education: Mr. Cronin holds BA from Muhlenberg College in Pennsylvania and has a Master’s in Business Administration in Finance from the University of Texas, Dallas.
  • Born: 1965
  • Holdings: 4 189 739 through shareholding in C3 Device Partners
  • Independence: Dependent in relation to the company, the company’s senior executives and major shareholders of the company.

KARIN ALMQVIST LIWENDAHL

Chief Financial Officer since 2020
Born 1962

Karin Almqvist Liwendahl has over 20 years of broad finance experience working for global companies in the telecom and life science industries Karin previously served as CFO for Sprint Bioscience, held international CFO and Managing Director positions within Telia , was CFO of Azercell, and was Director of Investor Relations for Ericsson.

Other appointments: Board member of Modelon, Board member of Nitator Stainless Steel AB,  Board member of Invarmex AB.

Education: Karin studied Strategic Finance and Strategic leadership for Women at IMD Lausanne and holds a BSc from Lund University

Holdings: none

 

JOSEPH COITE

Chief Operating Officer since 2021
Born 1957

Joseph Coite has over 30 years of operations, supply chain and logistics experience in the medical device industry, most recently as VP Operations at CoolSystems, manufacturers of the GameReady cold and compression system, where he previousy held positions in Supply Chain and Logistics. Other medical device experience includes roles in engineering at Modified Polyment Components, and in oprations at Zoll Medical Corporation, and AterG.

Dignitana will rely heavily on his ability to design and support innovative, integrated business solutions, lean concepts, contract manufacturing and team building, as well as his expertise spearheading technology-based initiatives to address customer needs and increase margins and revenue while reducing cost and waste.

Education: Mr. Coite has a BS in Organizational Behavior from University of San Francisco and received Lean Sensei certification from Gemba. He has completed multiple training programs focused on specific regulatory directives and operational efficiencies, most recently the Medical Device Single Audit Program (MDSAP) Regulations, Application of Risk Management and Analysis Techniques to Medical Devices, and US Export Controls.

Holdings: none

 

MELISSA BOURESTOM

Vice President Corporate Communications since 2016
Born 1967

Melissa Bourestom brings to Dignitana more than 25 years of experience in communications, marketing, sales and healthcare. Her expertise is in developing clear, concise messaging tailored to the audience and aligned with strategic objectives. She has been recognized for building strong customer relationships and effective utilization of traditional and digital marketing strategies. Prior to joining Dignitana she served as Executive Director of the American Advertising Federation Dallas and directed marketing and sales for myFootpath, an education technology start-up in Chicago. She previously worked in sales for Brinker International, in clinical services and pediatric neurology at Children’s Medical Center Dallas, and in account management at Spier Advertising NY.

Education: Ms. Bourestom holds a BA from Vanderbilt University – International Communications

Holdings: 5 000

 

SCOTT MCGOVERN

Regional Director Europe since 2017
Born 1971

Scott McGovern has worked with Dignitana for many years as the company’s agent in the United Kingdom through Nisus Medical.  He is an experienced team leader and has a proven background in market access, sales, and distribution of innovative medical equipment across the United Kingdom and Ireland. He has over 20 years’ experience in healthcare sales and marketing having previously worked in global companies such as Johnson & Johnson, Baxter Healthcare, Hospira, ICU Medical and Pfizer.

Holdings: none

 

JOHN MEYER

Vice President Regulatory and Quality Affairs since 2021
Born 1953

John Meyer has over 30 years of diverse experience in the medical device field including 20 years as a production manager and more than 10 years in Quality. Most recently he served as Senior Director of Quality for CoolSystems, manufacturers of the GameReady cold and compression system.  Previously he served as Manager of Quality for medical device company Transvivo and as Production Manager for Thoratec. His diverse operational scale-up experience in a highly regulated environment with a practical understanding of the associated production, quality and regulatory issues and requirements are a tremendous asset to Dignitana. 

Education: Mr. Meyer holds a BA in Psychology from University of California Santa Cruz and has completed graduate coursework in operations managemnt at both San Francisco State University and Virginia Polytechnic University.

Holdings: none

CAMERON O’MARA

Vice President Global Sales since 2019
Born 1979

Cameron O’Mara brings extensive experience originating new market opportunities for innovative products and services globally. After beginning his career at Arena Capital Partners LP, a middle market private equity firm in New York City, Cameron co-founded several global clean drinking water companies. As part of his duties he spearheaded project development efforts across over twenty emerging markets; establishing partnerships and formal dialogue with local influencers and government officials throughout. Cameron was invited to discuss creative solutions to improve fresh drinking water supplies and associated health standards with Heads of State and senior government ministers across three different continents.

Other appointments: Director, Hydro Nova LTD

Education: Mr. O’Mara holds a BA in Psychology from Harvard University

Holdings: none

 

Please note that the content of this website is not intended as professional medical or healthcare advice and should not be construed as a substitute for professional healthcare advice, or services from a qualified professional healthcare provider familiar with your unique situation. This content is intended solely as a general product and corporate information.

OPERATIONS
Dignitana
10925 Estate Lane, Suite 185
Dallas, TX 75238
+1 469-917-5555

HEADQUARTERS
Dignitana AB
Traktorgränden 3
226 60 Lund, Sweden
+46 46 16 30 90

HEADQUARTERS
Dignitana S.r.l.
Corso di Porta Nuova, 46
20121 Milan, Italy